Jyong Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.18	0.1	0.18	0.72	0.55
Short-Term Investments	-	-	-	0.09	1.83
Cash & Short-Term Investments	1.18	0.1	0.18	0.81	2.39
Cash Growth	1098.98%	-44.63%	-78.20%	-65.95%	-43.51%
Other Receivables	13.51	-	-	-	-
Total Trade Receivables	13.51	-	-	-	-
Other Current Assets	0.86	0.11	1.66	1.65	0.26
Total Current Assets	15.54	0.21	1.84	2.46	2.65
Net Property, Plant & Equipment	3.15	3.19	3.54	6	6.78
Other Long-Term Assets	2.08	2.97	2.87	0.28	0.01
Total Assets	20.78	6.37	8.25	8.75	9.43
Accounts Payable	0	0	0	0	0.05
Accrued Expenses	22.93	1.35	1.18	0.89	1.06
Short-Term Debt	7.71	7.23	7.9	7.17	4.76
Current Portion of Long-Term Debt	0.57	0.06	0.08	0.48	0.18
Current Portion of Leases	0.08	0.16	0.13	0.17	0.25
Other Current Liabilities	3.52	3.33	4.97	4.2	0
Total Current Liabilities	34.81	12.13	14.26	12.91	6.29
Long-Term Debt	10.16	10.68	8.52	6.32	6.26
Long-Term Leases	0.03	0.02	0.07	0.12	0.35
Other Long-Term Liabilities	0.69	20.06	19.47	19.04	19.86
Total Long-Term Liabilities	10.87	30.76	28.06	25.47	26.46
Total Liabilities	45.68	42.89	42.32	38.38	32.76
Common Stock	0	0	0	0	0
Treasury Stock	-16.37	-16.37	-16.37	-16.37	-16.37
Additional Paid-in Capital	28.53	11.81	11.81	11.81	11.81
Accumulated Other Comprehensive Income	0.68	1.12	0.55	0.59	0.27
Retained Earnings	-37.75	-33.08	-30.06	-25.66	-19.03
Shareholders' Equity	-24.91	-36.52	-34.07	-29.63	-23.33
Total Liabilities & Equity	20.78	6.37	8.25	8.75	9.43
Total Debt	18.55	18.14	16.69	14.25	11.79
Net Cash (Debt)	-17.37	-18.04	-16.51	-13.44	-9.4
Net Cash Per Share	-0.24	-0.25	-0.23	-0.19	-0.13
Book Value	-24.91	-36.52	-34.07	-29.63	-23.33
Book Value Per Share	-0.34	-0.51	-0.48	-0.41	-0.33
Tangible Book Value	-24.91	-36.52	-34.07	-29.63	-23.33
Tangible Book Value Per Share	-0.34	-0.51	-0.48	-0.41	-0.33

SEC Filings: 10-K · 10-Q